文献速递烧伤创面修复

烧伤患者非闭塞性肠系膜缺血的评估——配对分析及治疗方案

Evaluation of non-occlusive mesenteric ischemia for burn patients - A matched-pair analysis and treatment algorithm.
PubMed 文献 · Burns · 2024-08-30

回顾性分析2018年1月1日至2024年5月1日汉诺威医学院烧伤登记中20例烧伤患者,将发生非闭塞性肠系膜缺血(NOMI)者与未发生急性肠系膜缺血者按关键变量配对。NOMI组血清乳酸显著升高(p=0.005),更可能需要血管升压药的休克状态(p=0.047),80%死亡(p=0.024)。4例接受动脉内前列地尔给药,作者提出其作为NOMI靶向治疗的新方法。

要点

  • NOMI组血清乳酸显著升高(p=0.005),更可能处于需血管升压药的休克状态(p=0.047)。
  • NOMI组预后差,80%患者死亡(p=0.024)。
  • 4例患者接受动脉内前列地尔给药,作者提出其作为NOMI靶向治疗的新方法。

核心结论

  • NOMI对烧伤患者是潜在致命性疾病。
  • 目前缺乏敏感生物标志物和准确诊断工具以早期发现NOMI发病,是总体预后差的主要因素。
  • 作者提出动脉内给予前列地尔作为NOMI靶向治疗的新方法。

研究设计与样本

  • 回顾性描述性分析,基于汉诺威医学院整形、美容、手与重建外科烧伤登记,时间从2018年1月1日至2024年5月1日。
  • 将发生NOMI的烧伤患者与未发生急性肠系膜缺血的烧伤患者按关键变量和共同特征进行配对。
  • 共纳入20例患者。

主要发现

  • NOMI组血清乳酸显著升高(p=0.005)。
  • NOMI组更可能处于需要血管升压药的休克状态(p=0.047)。
  • NOMI组总体预后差,80%患者死亡(p=0.024)。
  • 共4例患者接受动脉内前列地尔给药。

临床怎么用

  • 作者提出动脉内给予前列地尔作为NOMI靶向治疗的新方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Burn injuries may cause gastrointestinal dysfunction leading to intestinal barrier dysfunction, abdominal compartment syndrome, and acute mesenteric ischemia. In the absence of major vascular occlusion, non-occlusive mesenteric ischemia (NOMI) often occurs in critically ill intensive-care burn patients. METHODS: A retrospective descriptive analysis of the burn registry of the Department of Plastic, Aesthetic, Hand and Reconstructive Surgery of Hannover Medical School was performed from 1st January 2018 to 1st May 2024. Burn patients with NOMI were matched with burn patients who did not acquire acute mesenteric ischemia based on key variables and shared characteristics. RESULTS: A total of 20 patients were included in this study. Patients with NOMI showed a statistically significant elevation in serum lactate (p = 0.005) and were most likely to be in a shock state requiring vasopressors (p = 0.047). Overall prognosis was poor for the NOMI cohort, 80 % of whom had a fatal result (p = 0.024). A total of four patients received intra-arterial administration of alprostadil. CONCLUSIONS: NOMI represents a potentially fatal condition for the burn patient. The current lack of sensitive biomarkers and accurate diagnostic tools for the early detection of NOMI onset is a major factor behind the overall poor prognosis. We propose the intra-arterial administration of alprostadil as a novel approach to targeted treatment for NOMI.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Bucher F, Dastagir N, Tamulevicius M, et al. Evaluation of non-occlusive mesenteric ischemia for burn patients - A matched-pair analysis and treatment algorithm. Burns. 2024. PMID: 39442475. doi:10.1016/j.burns.2024.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。